NFA
RKDA icon

Nationwide Fund Advisors’s Arcadia Biosciences RKDA Stock Holding History

Nationwide Fund Advisors’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-6
Closed -$13K – 3293
2016
Q1 		$13K Hold
6
– – ﹤0.01% 3127
2015
Q4 		$15K Hold
6
– – ﹤0.01% 3103
2015
Q3 		$15K Hold
6
– – ﹤0.01% 3146
2015
Q2 		$30K Buy
+6
New +$37.3K ﹤0.01% 3136

Other funds holding RKDA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nationwide Fund Advisors's RKDA Position: Q2 2016 in Review

Nationwide Fund Advisors sold out of Arcadia Biosciences (RKDA) in Q2 2016, closing a stake of 6 shares — an estimated $13K sold.

Nationwide Fund Advisors first reported a position in RKDA in Q2 2015 and held it in 4 quarters. The position peaked at $30K in Q2 2015. 20 funds tracked by Wall St. Rank hold RKDA as of Q2 2016.

  • Nationwide Fund Advisors reported no remaining Arcadia Biosciences position as of Q2 2016 after selling out during the quarter.
  • Nationwide Fund Advisors sold 6 Arcadia Biosciences shares in Q2 2016, an estimated $13K.
  • Nationwide Fund Advisors first reported a position in Arcadia Biosciences in Q2 2015 and held it in 4 quarters.
  • Nationwide Fund Advisors's Arcadia Biosciences position peaked at $30K in Q2 2015.
  • 20 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2016.

Based on Nationwide Fund Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.